SBCH turnover jumps 25% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

SBCH turnover jumps 25%

Apr 20, 2001

SmithKline Beecham Consumer Healthcare (SBCH) has declared a 26% jump in its 1QFY02 bottomline YoY. The company not only continues to show strong growth in its net profits, its topline too has grown by nearly 25% YoY.

(Rs m) 1QFY01 1QFY02 Change
Gross Sales 1,726 2,152 24.7%
Other Income 110 83 -24.5%
Expenditure 1,467 1,747 19.1%
Operating Profit (EBDIT) 259 406 56.6%
Operating Profit Margin (%) 15.0% 18.8%  
Interest 22 24 7.7%
Depreciation 37 33 -11.1%
Profit before Tax 311 432 38.9%
Tax 84 122 45.6%
Extraordinary expenses   24  
Profit after Tax/(Loss) 227 285 25.7%
Net profit margin (%) 13.2% 13.3%  
No. of Shares (eoy) (m) 45.4 45.4  
Diluted Earnings per share* 20.0 25.2  
Current P/e ratio   15.7  

SBCH is one of the few FMCG companies to show double digit growth in turnover. In FY01 too, the company finished the year with a 19% topline growth YoY.

SBCH strengthened its dominating position in the malted beverages segment with the acquisition of Viva and Maltova brands from Jagatjit Industries. The company is spending Rs 2.4 bn on a new plant (26,000 tonnes per annum) to manufacture 'Horlicks' (its main brand). This will enable it in overcoming a potential capacity constraint in the future. Moreover steps are being taken to increase capacity at its existing plant by 6,000 tonnes per annum. Productivity levels are expected to improve substantially as the new plant is based on the latest available technology. However, the profit margin growth of the company has stagnated, as it will not be able to capitalise the expenditure.

SBCH will act as a sourcing base for malted food drinks for the parent company’s other Asian markets, once the expanded capacity is commissioned. Horlicks exports will thereafter aid volume growth.

At the current levels, the SBCH stock quotes at a P/e multiple of 15.7 times its annualised 1QFY02 earnings. Given SBCH's consistent track record, the company will more likely than not emerge stronger after the capacity expansion.

Equitymaster requests your view! Post a comment on "SBCH turnover jumps 25%". Click here!


More Views on News

SYNGENE INTERNATIONAL at 52 Week High; BSE 500 Index Down 1.5 % (Market Updates)

Sep 24, 2020 | Updated on Sep 24, 2020

SYNGENE INTERNATIONAL share price has hit a 52-week high. It is presently trading at Rs 597. BSE 500 Index is down by 1.5% at 14,465. Within the BSE 500, SYNGENE INTERNATIONAL (up 5.5%) and GSK CONSUMER (up 5.1%) are among the top gainers, while top losers are SHRIRAM TRANSPORT and INDIABULLS REAL EST.

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Apr 15, 2020 (Close)


  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks